Loading...
XSHE000999
Market cap8.14bUSD
Dec 25, Last price  
46.67CNY
1D
0.67%
1Q
16.03%
Jan 2017
88.23%
Name

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:000999 chart
P/E
20.87
P/S
2.41
EPS
2.24
Div Yield, %
1.77%
Shrs. gr., 5y
5.45%
Rev. gr., 5y
13.00%
Revenues
24.74b
+36.83%
2,461,686,1222,969,474,2782,867,926,0713,397,843,5874,316,186,8844,852,717,0394,365,153,3155,525,222,9366,891,102,6327,801,603,7477,276,585,5717,900,189,5638,981,721,08011,119,916,37913,427,746,16214,701,918,76313,637,258,15315,319,993,63418,079,461,48224,738,963,319
Net income
2.85b
+16.50%
0119,934,235164,922,481279,797,200500,086,807709,489,009815,984,768760,447,5661,014,076,1211,181,104,7641,035,889,0141,249,226,5351,197,840,5991,301,687,2491,432,078,2012,112,494,7681,597,489,1752,055,104,4072,448,802,1032,852,931,664
CFO
4.22b
+40.38%
022,825,379425,505,881605,297,1941,116,375,222855,051,790848,277,111954,901,8951,211,832,6161,467,423,8251,184,427,7221,259,838,1831,392,140,6771,560,392,8231,911,246,8171,971,829,7662,223,984,7051,870,515,9683,006,375,0164,220,402,063
Dividend
Jun 14, 20241.5 CNY/sh

Profile

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.
IPO date
Mar 09, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
24,738,963
36.83%
18,079,461
18.01%
15,319,994
12.34%
Cost of revenue
18,517,953
14,237,691
12,006,165
Unusual Expense (Income)
NOPBT
6,221,011
3,841,771
3,313,828
NOPBT Margin
25.15%
21.25%
21.63%
Operating Taxes
580,975
466,425
348,219
Tax Rate
9.34%
12.14%
10.51%
NOPAT
5,640,036
3,375,345
2,965,609
Net income
2,852,932
16.50%
2,448,802
19.16%
2,055,104
28.65%
Dividends
(1,055,918)
(841,854)
(496,138)
Dividend yield
1.66%
1.84%
1.48%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
885,651
235,092
110,716
Long-term debt
2,041,955
261,859
185,382
Deferred revenue
455,501
423,190
395,128
Other long-term liabilities
676,377
119,688
129,148
Net debt
(6,024,120)
(5,600,854)
(3,987,782)
Cash flow
Cash from operating activities
4,220,402
3,006,375
1,870,516
CAPEX
(857,211)
Cash from investing activities
(821,735)
Cash from financing activities
450,425
FCF
1,639,863
2,918,724
1,968,763
Balance
Cash
8,226,787
3,149,709
4,283,880
Long term investments
724,938
2,948,096
Excess cash
7,714,777
5,193,832
3,517,880
Stockholders' equity
21,908,937
15,946,697
14,089,849
Invested Capital
20,031,567
12,755,444
12,552,567
ROIC
34.40%
26.67%
25.37%
ROCE
22.15%
21.15%
20.37%
EV
Common stock shares outstanding
1,278,900
978,900
978,900
Price
49.73
6.24%
46.81
36.71%
34.24
37.29%
Market cap
63,599,717
38.80%
45,822,309
36.71%
33,517,536
37.29%
EV
62,870,329
40,745,236
29,959,966
EBITDA
7,017,678
4,364,512
3,790,025
EV/EBITDA
8.96
9.34
7.90
Interest
85,174
21,227
13,267
Interest/NOPBT
1.37%
0.55%
0.40%